AKT1 and neoplasm: In addition to a fast reactivation of the MAPK pathway, we observed upregulation of AKT signaling, which is commonly observed upon MAPKi in other entities [37–39] and combination of MAPKi and PI3K/AKT/mTORi was shown to have beneficial effects in different tumor entities [40–42], including pLGGs [43].